Abstract
Rationale: Pretomanid is a new nitroimidazole with proven treatment-shortening efficacy in drug-resistant tuberculosis. Pretomanid-rifamycin-pyrazinam......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
